SAB BIO Announces Second Quarter 2024 Financial Results and Provides Company Updates
Provided By GlobeNewswire
Last update: Aug 8, 2024
FDA provided clearance to SAB’s IND
Appointed Lucy To as Chief Financial Officer
Announced founding of a new Clinical Advisory Board
Read more at globenewswire.com1.82
-0.13 (-6.67%)
NASDAQ:SABSW (2/21/2025, 8:00:01 PM)
0.0263
0 (-12.33%)
Find more stocks in the Stock Screener
